Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophy.

Discovery medicine

Volumn 14, Issue 74, 2012, Pages 59-69

  Kole, Ryszard ^a   Leppert, Brian J ^b  

^a AVI BIOPHARMA INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL; CLINICAL TRIAL (TOPIC); DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENETICS; HUMAN; METABOLISM; REVIEW; RNA SPLICING; TRANSLATIONAL RESEARCH;

ANIMALS; CLINICAL TRIALS AS TOPIC; GENETIC THERAPY; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE; RNA SPLICING; RNA, MESSENGER; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84874970703     PISSN: None     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Review

References (0)